Search

Search Results

1. Genetic characterization of duck hepatitis B viruses from Anhui Province, China

   Duck hepatitis B virus (DHBV) infection model was frequently used as the experimental model for human hepatitis B virus (HBV) research. In order to...

   Yumeng Ye, Yong Wang, ... Chuanfeng Li in Brazilian Journal of Microbiology

   Article 06 September 2023
   

2. Structural basis of hepatitis B virus receptor binding

   Hepatitis B virus (HBV), a leading cause of develo** hepatocellular carcinoma affecting more than 290 million people worldwide, is an enveloped DNA...

   **ta Asami, Jae-Hyun Park, ... Umeharu Ohto in Nature Structural & Molecular Biology

   Article 17 January 2024
   

3. Frequency of B-Cell Subpopulations in Low Responders in Comparison with High Responders to Hepatitis B Vaccine Among Health Care Workers

   Vaccination is the most effective way to prevent Hepatitis B (HB) infection. The goal of vaccination is to induce immunological memory. Hence,...

   Zahra Saleh, Fereshteh Mehdipour, ... Kurosh Kalantar in Current Microbiology

   Article 24 July 2023
   

4. MiR-3677-3p promotes development and sorafenib resistance of hepatitis B-related hepatocellular carcinoma by inhibiting FOXM1 ubiquitination

   Being encoded by hepatitis B, hepatitis B X (HBx) protein plays crucial roles in hepatitis B-related hepatocellular carcinoma (HCC) occurrence,...

   Hengzheng He, Jian Zhou, ... Yangya Quan in Human Cell

   Article 05 July 2023
   

5. HBx Protein Potentiates Hepatitis B Virus Reactivation

   Abstract

   Hepatitis B virus (HBV) can cause chronic hepatitis B, one of the most prevalent infectious diseases in the world. Global estimates suggest...

   S. A. Brezgin, A. P. Kostyusheva, ... D. S. Kostyushev in Molecular Biology

   Article 05 October 2022
   

6. Hepatitis B virus-induced hepatocellular carcinoma: a persistent global problem

   Hepatitis B virus (HBV) infections are highly prevalent globally, representing a serious public health problem. The diverse modes of transmission and...

   Sanjit Boora, Vikrant Sharma, ... Samander Kaushik in Brazilian Journal of Microbiology

   Article 14 April 2023
   

7. Systematic analysis on the mechanism of Zhizi-Bopi decoction against hepatitis B via network pharmacology and molecular docking

   Purpose: Zhizi-Bopi decoction (ZZBPD) is a classic herbal formula with wide clinical applications in treating liver diseases including hepatitis B....

   He Zhang, Zhouyi Xu, ... Qinyuan Zhang in Biotechnology Letters

   Article 18 February 2023
   

8. Data-independent acquisition-based mass spectrometry(DIA-MS) for quantitative analysis of patients with chronic hepatitis B

   Chronic hepatitis B is a significant public health problem and complex pathologic process, and unraveling the underlying mechanisms and...

   Bo Wang, Qian Zhang, ... Gang Qin in Proteome Science

   Article Open access 06 June 2023
   

9. Interleukin-16 genetic polymorphisms in Guangxi Chinese with hepatitis B virus-related liver cirrhosis

   Background

   Our previous study has reported that interleukin-16 (IL-16) genetic polymorphisms are significantly related to chronic hepatitis B (CHB)...

   **aolian Zhang, Wenjun Tang, ... Dong Liang in Molecular Biology Reports

   Article 03 May 2023
   

10. Hepatitis B Virus Genotypes in Patients with Hepatitis D as Determined by the Panel of Their Own Development of Monoclonal Antibodies

    Direct genoty** of hepatitis B virus (HBV) in samples from patients with hepatitis delta can be impossible due to an undetectable concentration of...

    L. V. Bezuglova, O. V. Isaeva, ... I. G. Netesova in Molecular Genetics, Microbiology and Virology

    Article 01 June 2022

11. ViroISDC: a method for calling integration sites of hepatitis B virus based on feature encoding

    Background

    Hepatitis B virus (HBV) integrates into human chromosomes and can lead to genomic instability and hepatocarcinogenesis. Current tools for...

    Lei Qiao, Chang Li, ... **gyang Gao in BMC Bioinformatics

    Article Open access 04 May 2024
    

12. The role of HBV cccDNA in occult hepatitis B virus infection

    Occult hepatitis B virus (HBV) infection (OBI) refers to the presence of replication-competent HBV DNA in the liver, with or without HBV DNA in the...

    Pei He, Peixin Zhang, ... Jilu Shen in Molecular and Cellular Biochemistry

    Article 03 February 2023
    

13. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma

    Background

    Hepatocellular carcinoma (HCC) ranks as the third most common cause of cancer related death globally, representing a substantial challenge...

    Zhuo Li, Na Zhang, ... Zengqi Tan in Cell Communication and Signaling

    Article Open access 01 April 2024
    

14. Catenulopyrizomicins, new anti-Hepatitis B virus compounds, from the rare actinomycete Catenuloplanes sp. MM782L-181F7

    Hepatitis B virus (HBV) causes chronic hepatitis in humans, and current antiviral therapies rarely treat viral infections. To improve the treatment...

    Manabu Yamasaki, Ryuichi Sawa, ... Masayuki Igarashi in The Journal of Antibiotics

    Article 27 November 2023
    

15. Antiviral Activity of CRISPR/Cas9 Ribonucleoprotein Complexes on a Hepatitis B Virus Model In Vivo

    Abstract

    Chronic hepatitis B (CHB) is caused by hepatitis B virus (HBV) infection. This disease is a key issue for global health. Modern methods of...

    A. P. Kostyusheva, S. A. Brezgin, ... D. S. Kostyushev in Molecular Biology

    Article 09 December 2022
    

16. Fibroblast Growth Factor 11 Inhibits Hepatitis B Virus Gene Expression Through FXRα Suppression

    Fibroblast growth factor 11 (FGF11) is a member of the intracellular FGF family, which shows different signal transmission compared with other FGF...

    Mi So Seong, Jeong Ah Jang, ... JaeHun Cheong in Journal of Microbiology

    Article Open access 01 July 2023
    

17. Serum HBV RNA levels among untreated adults with chronic hepatitis B in distinct immune phases and liver histopathology statuses

    HBV RNA is a novel serum biomarker that reflects intrahepatic HBV covalently closed circular DNA (cccDNA) transcription activity. Serum HBV RNA...

    Qin Xu, Hai Ding, ... Yuxin Chen in Journal of Molecular Histology

    Article 16 October 2023
    

18. Insights into the impact of hepatitis B virus on hepatic stellate cell activation

    During chronic hepatitis B virus (HBV) infection, hepatic fibrosis is a serious pathological condition caused by virus-induced liver damage. The...

    Hongjuan You, **ng Wang, ... Renxian Tang in Cell Communication and Signaling

    Article Open access 11 April 2023
    

19. Association Between Serum Levels of Anti-heat Shock Protein 27 Antibody and Liver Cell Injury in Chronic Hepatitis B

    Heat Shock Protein 27 (HSP27), an anti-HBV factor, exists in the intracellular and extracellular spaces. As an inflammatory modulator, serum HSP27...

    Zahra Yousefli, Zahra Meshkat, ... Aida Gholoobi in Indian Journal of Clinical Biochemistry

    Article 31 January 2023
    

20. Dihydromyricetin inhibits Hepatitis B virus replication by activating NF-κB, MAPKs, and autophagy in HepG2.2.15 cells

    Background

    Hepatitis B virus (HBV) infection is a severe global health problem, and there has been no effective method to eliminate HBV. This study...

    Xuefeng Wang, Haiming Hu, ... Hongtao Liu in Molecular Biology Reports

    Article 06 December 2022